Exagen Inc. announced the formation of its new Scientific Advisory Board (SAB) with appointment of seven doctors and rheumatology experts. The SAB includes Stanley Cohen, MD; Andrew Concoff, MD, FACR, CAQSM; Kevin Deane, MD, PhD; Paul J. DeMarco, MD; Harris Perlman, PhD; Eric Ruderman, MD; and Marina Sirota, PhD. The founding members of the Exagen RA Scientific Advisory Board are: Stanley Cohen, M.D. is a Clinical Professor in the Department of Internal Medicine at UT Southwestern Medical Center and Co-Director of the Division of Rheumatology at Presbyterian Hospital, Dallas.

Andrew Concoff, MD, FACR, CAQSM is the Executive Vice President, Chief Medical Officer at United Rheumatology. Kevin Deane, MD, PhD is a Professor of Medicine in the Division of Rheumatology at the University of Colorado Anschutz Medical Campus. Paul J. DeMarco, M.D. is a Board-Certified Rheumatologist, a Fellow of the American College of Physicians, a Fellow of the American College of Rheumatology and a member of the American Institute of Ultrasound in Medicine.

Harris Perlman, PhD is Chief of Rheumatology and the Mabel Greene Myers Professor of Medicine and was the co-senior author of a USA-based study that used genetic profiling of joint tissue to see which drugs would work for which patients. Eric Ruderman, MD is the Associate Chief, Clinical Affairs for the Division of Rheumatology at Northwestern University Feinberg School of Medicine. Marina Sirota, PhD is an Associate Professor at the Bakar Computational Health Sciences Institute at UCSF.